| 000 | 01693 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250517194831.0 | ||
| 264 | 0 | _c20181101 | |
| 008 | 201811s 0 0 eng d | ||
| 022 | _a1469-4409 | ||
| 024 | 7 |
_a10.1017/S0950268817003016 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSong, Y X | |
| 245 | 0 | 0 |
_aPrevalence of transmitted drug resistance among HIV-1 treatment-naive patients in Beijing. _h[electronic resource] |
| 260 |
_bEpidemiology and infection _c02 2018 |
||
| 300 |
_a339-344 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xepidemiology |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xpharmacology |
| 650 | 0 | 4 |
_aBeijing _xepidemiology |
| 650 | 0 | 4 |
_aDrug Resistance, Viral _xgenetics |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHomosexuality, Male |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 |
_aProtease Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aXin, R L | |
| 700 | 1 | _aLi, Z C | |
| 700 | 1 | _aYu, H W | |
| 700 | 1 | _aLun, W H | |
| 700 | 1 | _aYe, J | |
| 700 | 1 | _aLiu, A | |
| 700 | 1 | _aLi, A X | |
| 700 | 1 | _aLi, J W | |
| 700 | 1 | _aYe, J Z | |
| 700 | 1 | _aHao, M Q | |
| 700 | 1 | _aLu, H Y | |
| 700 | 1 | _aSun, L J | |
| 773 | 0 |
_tEpidemiology and infection _gvol. 146 _gno. 3 _gp. 339-344 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1017/S0950268817003016 _zAvailable from publisher's website |
| 999 |
_c27991207 _d27991207 |
||